Stock Fundamentals

Company Information

Company Name
Trevi Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US89532M1018
CIK: 0001563880
CUSIP: 89532M101
Currency: USD
Full Time Employees: 34
Phone: 203 304 2499
Fiscal Year End: December
IPO Date: May 07, 2019
Description:

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough. The company develops Haduvio, an oral extended-release formulation of nalbuphine, which is in phase 2b Cough Reduction in IPF with nalbuphine ER clinical trial for treatment of chronic cough in patients with IPF, and phase 2a clinical trial in patients with refractory chronic cough. Trevi Therapeutics, Inc. has a license agreement with Keenova Therapeutics plc to develop and commercialize products incorporating nalbuphine hydrochloride in various formulations. Trevi Therapeutics, Inc. was incorporated in 2011 and is headquartered in New Haven, Connecticut.

Address:

195 Church Street, New Haven, CT, United States, 06510

Directors & Officers

Name Title Year Born
Ms. Jennifer L. Good Co-Founder, CEO, President, & Director 1965
Dr. James V. Cassella Ph.D. Chief Development Officer 1955
Mr. Farrell Simon Pharm.D. Chief Commercial Officer NA
Dr. Thomas R. Sciascia M.D. Co-Founder & Chief Scientific Officer 1953
Mr. David C. Hastings CPA Chief Financial Officer & Principal Financial Officer 1961
Mr. Christopher Galletta Controller & Chief Accounting Officer 1978
Katie McManus Communications Manager NA
Ms. Katherine Takaki Ph.D. Senior VP of Global Regulatory Affairs NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 21, 2025 Jennifer L Good N/A Sale 5.26K $6.58 $34.63K
Mar 10, 2025 Farrell Simon N/A Sale 81.31K $6.75 $548.86K
Sep 09, 2024 Jennifer L Good N/A Sale 1.84K $3.04 $5.59K
Sep 06, 2024 Jennifer L Good N/A Sale 4.22K $3.03 $12.78K
Sep 04, 2024 Jennifer L Good N/A Sale 10.98K $3.02 $33.16K
Aug 27, 2024 David P Meeker N/A Sale 4.56K $2.93 $13.35K
Aug 16, 2024 Thomas Sciascia N/A Sale 18.66K $2.76 $51.50K
Aug 14, 2024 Thomas Sciascia N/A Sale 100.00 $2.75 $275.00
May 29, 2024 Thomas Sciascia N/A Sale 53.37K $2.55 $136.09K
May 22, 2024 Lisa Delfini N/A Sale 4.35K $2.64 $11.48K
May 20, 2024 Jennifer L Good N/A Sale 25.04K $2.86 $71.61K
May 10, 2024 Jennifer L Good N/A Sale 4.58K $2.90 $13.28K
Oct 11, 2023 Lisa Delfini N/A Sale 785.00 $2.02 $1.59K
Sep 11, 2023 Lisa Delfini N/A Sale 711.00 $2.20 $1.56K
Aug 11, 2023 Lisa Delfini N/A Sale 682.00 $2.36 $1.61K
Jul 11, 2023 Lisa Delfini N/A Sale 687.00 $2.34 $1.61K
Jun 12, 2023 Lisa Delfini N/A Sale 610.00 $2.64 $1.61K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
NEA Management Company, LLC 13.22M Mar 31, 2026 9.31% $8.97 0.00%
BlackRock Inc 10.24M Mar 31, 2026 7.21% $0.00 1.13%
Frazier Life Sciences Management, L.P. 9.94M Mar 31, 2026 7.00% $3.05 -3.12%
FMR Inc 8.04M Mar 31, 2026 5.66% $0.01 23.66%
Vanguard Group Inc 6.43M Dec 31, 2025 4.53% $0.00 10.43%
Wellington Management Company LLP 5.19M Mar 31, 2026 3.65% $0.01 52.44%
Vivo Capital, LLC 5.09M Mar 31, 2026 3.59% $5.05 0.00%
Vanguard Capital Management, LLC 4.98M Mar 31, 2026 3.51% $0.00 0.00%
Marshall Wace Asset Management Ltd 3.97M Mar 31, 2026 2.79% $0.05 -13.42%
Rubric Capital Management LP 3.71M Mar 31, 2026 2.61% $0.47 -1.44%
MPM Oncology Impact Management LP 3.30M Mar 31, 2026 2.32% $3.04 0.35%
Viking Global Investors LP 3.20M Mar 31, 2026 2.25% $0.11 0.00%
AllianceBernstein L.P. 2.85M Mar 31, 2026 2.00% $0.01 -7.70%
Geode Capital Management, LLC 2.78M Mar 31, 2026 1.96% $0.00 15.14%
State Street Corp 2.67M Mar 31, 2026 1.88% $0.00 9.46%
Eventide Asset Management, LLC 2.62M Mar 31, 2026 1.85% $0.52 0.00%
Orbimed Advisors, LLC 2.45M Mar 31, 2026 1.73% $0.58 -23.08%
Logos Global Management LP 2.40M Mar 31, 2026 1.69% $1.43 54.84%
Vestal Point Capital LP 2.17M Mar 31, 2026 1.53% $0.72 0.00%
Artia Global Partners LP 2.01M Mar 31, 2026 1.42% $4.81 0.00%

Shares Statistics

Shares Outstanding: 141.98M
Shares Float: 117.83M
% Insiders: 63.00%
% Institutions: 9,829.90%
Short % Float: 10.62%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 4.02M 2.83% ▲ 8.68% Apr 30, 2026
2 Eventide Healthcare & Life Sciences I 2.62M 1.85% ▲ 0.00% Mar 31, 2026
3 Fidelity Select Biotechnology 2.37M 1.67% ▼ 0.16% Apr 30, 2026
4 iShares Russell 2000 ETF 2.28M 1.61% ▲ 0.93% May 29, 2026
5 MEDICAL BioHealth EUR Acc 1.39M 0.98% ▼ 0.07% Apr 30, 2026
6 Fidelity Growth Compy Commingled Pl S 1.37M 0.97% ▲ 101.26% Apr 30, 2026
7 Vanguard Institutional Extnd Mkt Idx Tr 1.31M 0.92% ▲ 12.58% Apr 30, 2026
8 Fidelity Small Cap Growth 1.29M 0.91% ▲ 0.00% Mar 31, 2026
9 AB Small Cap Growth A 1.20M 0.84% ▼ 4.26% Apr 30, 2026
10 Pictet-Biotech P USD 1.11M 0.78% ▲ 0.40% Feb 28, 2026

Valuation Metrics

Enterprise Value: $1.85B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $2.02B
EBITDA: $-52.63M
Book Value: $1.34
Earnings/Share: $-0.32
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -23.02%
ROE (TTM): -33.59%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 19.66x 0.00x 0.05x N/A -0.01x
2024-12-31 10.41x 0.00x 0.10x -12,881.00x -0.01x
2023-12-31 15.03x 0.00x 0.08x -86.76x -0.01x
2022-12-31 9.15x 0.09x 0.13x -38.34x -0.31x
2021-12-31 2.98x 0.86x 0.56x -27.02x -0.45x
2020-12-31 8.33x 0.52x 0.42x -71.25x -0.43x
2019-12-31 11.45x 0.00x 0.09x -43.25x 0.00x
2018-12-31 7.02x 0.06x 0.16x -105.79x -0.06x
2017-12-31 3.11x 0.36x 0.34x -2.46x -0.65x
2016-12-31 0.41x -1.27x 3.07x N/A -2.56x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about TRVI.US!